TurnerTrends Stock Rating Report for AKRX
Data valid for week beginning June 29, 2009
|
AKRX [News]
|
Akorn Inc
|
Company Profile
"Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in the areas of ophthalmology, rheumatology, anesthesia, and antidotes in the United States. The companyÂ’s Ophthalmic Segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. It also sells therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants-antihistamines, and anti-edema medications to wholesalers and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The companyÂ’s Hospital Drugs and Injectables Segment markets specialty injectable pharmaceutical products, including antidotes and anesthesia, as well as products used in the treatment of rheumatoid arthritis and pain management. It markets products to hospitals through wholesalers and other national account customers, as well as directly to medical specialists. The companyÂ’s Biologics and Vaccines Segment markets adult Tetanus-Diphtheria vaccines directly to hospitals and physicians, as well as through wholesalers and national distributors. Its Contract Services Segment manufactures products for third party pharmaceutical and biotechnology customers. The company also markets and distributes vaccines purchased from outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and other pharmaceutical companies. The company has strategic partnerships with Strides Arcolab Limited- Serum Institute of India, Ltd.- Hameln Pharmaceuticals- and Cipla, Ltd. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Latest News
| Wed, 17 Jun 2009 13:53:00 Etc/GMT | Akorn Acquires Capastat® Sulfate from Eli Lilly and Company (Business Wire) | | Fri, 12 Jun 2009 20:41:00 Etc/GMT | AKORN INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | | Thu, 11 Jun 2009 16:39:00 Etc/GMT | A Shooting STAAR in the Eye Care Sector (Indie Research) | | Tue, 9 Jun 2009 13:18:00 Etc/GMT | Akorn Announces Management Changes (Business Wire) | | Tue, 2 Jun 2009 13:02:16 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online) | | Thu, 28 May 2009 14:15:25 Etc/GMT | Pequot Capital Closes: Expect Downward Pressure on Top Holdings (at Seeking Alpha) | | Wed, 20 May 2009 13:04:36 Etc/GMT | AKORN INC Financials (EDGAR Online Financials) | | Thu, 14 May 2009 20:27:48 Etc/GMT | AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online) | | Wed, 13 May 2009 13:28:32 Etc/GMT | New Star Analyst Rankings for Akorn, Inc. (StarMine) | | Tue, 12 May 2009 11:00:00 Etc/GMT | Akorn Reports First Quarter 2009 Financial Results (Business Wire) | | Mon, 11 May 2009 20:41:34 Etc/GMT | AKORN INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Tue, 21 Apr 2009 20:10:07 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online) | | Fri, 17 Apr 2009 20:12:59 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online) | | Mon, 6 Apr 2009 20:11:02 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o (EDGAR Online) | | Mon, 30 Mar 2009 13:41:21 Etc/GMT | AKORN INC Files SEC form 10-K, Annual Report (EDGAR Online) | | Tue, 3 Mar 2009 11:03:06 Etc/GMT | AKORN INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | | Wed, 25 Feb 2009 21:28:28 Etc/GMT | AKORN INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online) | | Tue, 3 Feb 2009 21:46:38 Etc/GMT | AKORN INC Files SEC form 8-K, Termination of a Material Definitive Agreement (EDGAR Online) | | Wed, 28 Jan 2009 17:20:00 Etc/GMT | Shooting Up With A Small-Cap (at Forbes.com) | | Fri, 9 Jan 2009 11:01:58 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online) | News provided by Yahoo! Finance |
|
